NVAX Q1 2017 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+34.7% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$41M-718.8% margin

Net Income

-$44M-772.1% margin

EPS (Diluted)

$-3.20

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$362M

Total Liabilities

$391M

Stockholders' Equity

-$29M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+34.7%
Gross Profit	$6M	$4M	+34.7%
Operating Income	-$41M	-$75M	+45.8%
Net Income	-$44M	-$77M	+43.2%